nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—type 2 diabetes mellitus—hypertension	0.343	1	CtDrD
Gliclazide—KCNJ11—hypertension	0.112	0.504	CbGaD
Gliclazide—VEGFA—hypertension	0.0865	0.391	CbGaD
Gliclazide—VEGFA—Carvedilol—hypertension	0.0718	0.288	CbGbCtD
Gliclazide—KCNJ11—Minoxidil—hypertension	0.0456	0.183	CbGbCtD
Gliclazide—ALB—hypertension	0.0233	0.105	CbGaD
Gliclazide—KCNJ11—Verapamil—hypertension	0.0136	0.0546	CbGbCtD
Gliclazide—ALB—Ethacrynic acid—hypertension	0.00907	0.0364	CbGbCtD
Gliclazide—CYP2C9—Eprosartan—hypertension	0.006	0.0241	CbGbCtD
Gliclazide—CYP2C19—Torasemide—hypertension	0.00588	0.0236	CbGbCtD
Gliclazide—ALB—Valsartan—hypertension	0.00585	0.0235	CbGbCtD
Gliclazide—CYP2C19—Metoprolol—hypertension	0.00547	0.0219	CbGbCtD
Gliclazide—CYP2C19—Guanfacine—hypertension	0.00547	0.0219	CbGbCtD
Gliclazide—CYP2C9—Torasemide—hypertension	0.00489	0.0196	CbGbCtD
Gliclazide—CYP2C9—Guanfacine—hypertension	0.00455	0.0182	CbGbCtD
Gliclazide—CYP2C9—Candesartan—hypertension	0.00455	0.0182	CbGbCtD
Gliclazide—CYP2C19—Doxazosin—hypertension	0.00429	0.0172	CbGbCtD
Gliclazide—ALB—Captopril—hypertension	0.00427	0.0171	CbGbCtD
Gliclazide—CYP2C19—Diltiazem—hypertension	0.00414	0.0166	CbGbCtD
Gliclazide—CYP2C19—Telmisartan—hypertension	0.0039	0.0156	CbGbCtD
Gliclazide—CYP2C9—Diltiazem—hypertension	0.00345	0.0138	CbGbCtD
Gliclazide—ALB—Furosemide—hypertension	0.00343	0.0137	CbGbCtD
Gliclazide—ALB—Losartan—hypertension	0.00336	0.0135	CbGbCtD
Gliclazide—CYP2C9—Valsartan—hypertension	0.00315	0.0126	CbGbCtD
Gliclazide—CYP2C19—Timolol—hypertension	0.00314	0.0126	CbGbCtD
Gliclazide—CYP2C19—Nicardipine—hypertension	0.00304	0.0122	CbGbCtD
Gliclazide—CYP2C9—Irbesartan—hypertension	0.00281	0.0113	CbGbCtD
Gliclazide—CYP2C19—Propranolol—hypertension	0.0028	0.0112	CbGbCtD
Gliclazide—CYP2C9—Amlodipine—hypertension	0.00275	0.011	CbGbCtD
Gliclazide—CYP2C9—Felodipine—hypertension	0.00266	0.0107	CbGbCtD
Gliclazide—CYP2C9—Nifedipine—hypertension	0.00257	0.0103	CbGbCtD
Gliclazide—CYP2C9—Carvedilol—hypertension	0.00253	0.0101	CbGbCtD
Gliclazide—CYP2C9—Nicardipine—hypertension	0.00253	0.0101	CbGbCtD
Gliclazide—CYP2C19—Atorvastatin—hypertension	0.00238	0.00955	CbGbCtD
Gliclazide—CYP2C19—Losartan—hypertension	0.00218	0.00873	CbGbCtD
Gliclazide—CYP2C9—Atorvastatin—hypertension	0.00198	0.00794	CbGbCtD
Gliclazide—CYP2C19—Verapamil—hypertension	0.00192	0.00771	CbGbCtD
Gliclazide—CYP2C9—Losartan—hypertension	0.00181	0.00726	CbGbCtD
Gliclazide—CYP2C9—Verapamil—hypertension	0.0016	0.00641	CbGbCtD
Gliclazide—VEGFA—cardiac ventricle—hypertension	0.000813	0.0665	CbGeAlD
Gliclazide—CYP2C19—urine—hypertension	0.000792	0.0647	CbGeAlD
Gliclazide—VEGFA—myocardium—hypertension	0.000765	0.0625	CbGeAlD
Gliclazide—CYP2C9—urine—hypertension	0.000614	0.0502	CbGeAlD
Gliclazide—VEGFA—nephron tubule—hypertension	0.000561	0.0458	CbGeAlD
Gliclazide—VEGFA—adrenal cortex—hypertension	0.000552	0.0451	CbGeAlD
Gliclazide—VEGFA—heart—hypertension	0.000534	0.0436	CbGeAlD
Gliclazide—VEGFA—smooth muscle tissue—hypertension	0.00053	0.0433	CbGeAlD
Gliclazide—VEGFA—decidua—hypertension	0.000519	0.0424	CbGeAlD
Gliclazide—VEGFA—cortex of kidney—hypertension	0.00048	0.0392	CbGeAlD
Gliclazide—VEGFA—cardiac atrium—hypertension	0.000457	0.0373	CbGeAlD
Gliclazide—VEGFA—Timolol—Penbutolol—hypertension	0.000412	0.236	CbGdCrCtD
Gliclazide—Tolazamide—KCNJ1—hypertension	0.000411	0.153	CrCbGaD
Gliclazide—ABCC8—brainstem—hypertension	0.000407	0.0332	CbGeAlD
Gliclazide—VEGFA—adrenal gland—hypertension	0.000399	0.0326	CbGeAlD
Gliclazide—KCNJ11—heart—hypertension	0.000382	0.0312	CbGeAlD
Gliclazide—Glimepiride—KCNJ1—hypertension	0.000366	0.137	CrCbGaD
Gliclazide—KCNJ11—cardiovascular system—hypertension	0.000361	0.0295	CbGeAlD
Gliclazide—ABCC8—heart—hypertension	0.000352	0.0288	CbGeAlD
Gliclazide—ABCC8—smooth muscle tissue—hypertension	0.000349	0.0285	CbGeAlD
Gliclazide—ABCC8—cardiovascular system—hypertension	0.000332	0.0271	CbGeAlD
Gliclazide—ABCC8—kidney—hypertension	0.000325	0.0265	CbGeAlD
Gliclazide—Glisoxepide—KCNJ8—hypertension	0.000322	0.12	CrCbGaD
Gliclazide—KCNJ11—adrenal gland—hypertension	0.000285	0.0233	CbGeAlD
Gliclazide—ABCC8—medulla oblongata—hypertension	0.000284	0.0232	CbGeAlD
Gliclazide—ABCC8—adrenal gland—hypertension	0.000263	0.0215	CbGeAlD
Gliclazide—ALB—heart—hypertension	0.000252	0.0206	CbGeAlD
Gliclazide—KCNJ11—endocrine gland—hypertension	0.000247	0.0202	CbGeAlD
Gliclazide—ABCC8—endocrine gland—hypertension	0.000228	0.0186	CbGeAlD
Gliclazide—Tolbutamide—KCNJ1—hypertension	0.000224	0.0834	CrCbGaD
Gliclazide—KCNJ11—central nervous system—hypertension	0.000223	0.0182	CbGeAlD
Gliclazide—ABCC8—central nervous system—hypertension	0.000205	0.0168	CbGeAlD
Gliclazide—VEGFA—Enalapril—Captopril—hypertension	0.000192	0.11	CbGdCrCtD
Gliclazide—ALB—adrenal gland—hypertension	0.000188	0.0154	CbGeAlD
Gliclazide—Tolazamide—KCNJ11—hypertension	0.000162	0.0603	CrCbGaD
Gliclazide—CYP2C9—heart—hypertension	0.000157	0.0129	CbGeAlD
Gliclazide—Glyburide—KCNJ1—hypertension	0.000155	0.0578	CrCbGaD
Gliclazide—CYP2C9—cardiovascular system—hypertension	0.000148	0.0121	CbGeAlD
Gliclazide—Glisoxepide—KCNJ11—hypertension	0.000146	0.0545	CrCbGaD
Gliclazide—Glimepiride—KCNJ11—hypertension	0.000144	0.0537	CrCbGaD
Gliclazide—Glyburide—ABCC9—hypertension	0.00014	0.0523	CrCbGaD
Gliclazide—VEGFA—Enalapril—Fosinopril—hypertension	0.000137	0.0782	CbGdCrCtD
Gliclazide—CYP2C19—endocrine gland—hypertension	0.000131	0.0107	CbGeAlD
Gliclazide—Glipizide—KCNJ11—hypertension	0.000125	0.0466	CrCbGaD
Gliclazide—VEGFA—Enalapril—Moexipril—hypertension	0.000119	0.0678	CbGdCrCtD
Gliclazide—VEGFA—Enalapril—Perindopril—hypertension	0.000104	0.0593	CbGdCrCtD
Gliclazide—CYP2C9—endocrine gland—hypertension	0.000102	0.00832	CbGeAlD
Gliclazide—VEGFA—Enalapril—Quinapril—hypertension	9.83e-05	0.0562	CbGdCrCtD
Gliclazide—VEGFA—Enalapril—Benazepril—hypertension	9.59e-05	0.0549	CbGdCrCtD
Gliclazide—Chlorpropamide—KCNJ11—hypertension	9.04e-05	0.0337	CrCbGaD
Gliclazide—Tolbutamide—KCNJ11—hypertension	8.81e-05	0.0328	CrCbGaD
Gliclazide—VEGFA—Pindolol—Nadolol—hypertension	8.47e-05	0.0485	CbGdCrCtD
Gliclazide—VEGFA—Enalapril—Trandolapril—hypertension	8.09e-05	0.0463	CbGdCrCtD
Gliclazide—VEGFA—Pindolol—Acebutolol—hypertension	7.46e-05	0.0427	CbGdCrCtD
Gliclazide—Tolbutamide—CYP2C18—hypertension	7.38e-05	0.0275	CrCbGaD
Gliclazide—Glipizide—PPARG—hypertension	6.93e-05	0.0258	CrCbGaD
Gliclazide—VEGFA—Pindolol—Metoprolol—hypertension	6.77e-05	0.0388	CbGdCrCtD
Gliclazide—VEGFA—Pindolol—Esmolol—hypertension	6.42e-05	0.0367	CbGdCrCtD
Gliclazide—VEGFA—Enalapril—Lisinopril—hypertension	6.33e-05	0.0362	CbGdCrCtD
Gliclazide—VEGFA—Enalapril—Ramipril—hypertension	6.13e-05	0.0351	CbGdCrCtD
Gliclazide—Glyburide—KCNJ11—hypertension	6.1e-05	0.0228	CrCbGaD
Gliclazide—VEGFA—Pindolol—Betaxolol—hypertension	5.65e-05	0.0323	CbGdCrCtD
Gliclazide—Glyburide—ABCC1—hypertension	5.53e-05	0.0206	CrCbGaD
Gliclazide—VEGFA—Pindolol—Propranolol—hypertension	3.84e-05	0.0219	CbGdCrCtD
Gliclazide—Chlorpropamide—PTGS1—hypertension	3.7e-05	0.0138	CrCbGaD
Gliclazide—Glyburide—ALB—hypertension	1.27e-05	0.00474	CrCbGaD
Gliclazide—Abdominal pain—Perindopril—hypertension	8.5e-06	7.85e-05	CcSEcCtD
Gliclazide—Body temperature increased—Perindopril—hypertension	8.5e-06	7.85e-05	CcSEcCtD
Gliclazide—Palpitations—Lisinopril—hypertension	8.49e-06	7.84e-05	CcSEcCtD
Gliclazide—Diarrhoea—Olmesartan—hypertension	8.49e-06	7.84e-05	CcSEcCtD
Gliclazide—Headache—Eplerenone—hypertension	8.49e-06	7.84e-05	CcSEcCtD
Gliclazide—Rash—Nifedipine—hypertension	8.48e-06	7.83e-05	CcSEcCtD
Gliclazide—Nervous system disorder—Ramipril—hypertension	8.48e-06	7.83e-05	CcSEcCtD
Gliclazide—Dermatitis—Nifedipine—hypertension	8.47e-06	7.82e-05	CcSEcCtD
Gliclazide—Body temperature increased—Irbesartan—hypertension	8.47e-06	7.82e-05	CcSEcCtD
Gliclazide—Abdominal pain—Irbesartan—hypertension	8.47e-06	7.82e-05	CcSEcCtD
Gliclazide—Thrombocytopenia—Ramipril—hypertension	8.46e-06	7.82e-05	CcSEcCtD
Gliclazide—Loss of consciousness—Lisinopril—hypertension	8.44e-06	7.8e-05	CcSEcCtD
Gliclazide—Rash—Verapamil—hypertension	8.44e-06	7.8e-05	CcSEcCtD
Gliclazide—Urticaria—Hydrochlorothiazide—hypertension	8.44e-06	7.8e-05	CcSEcCtD
Gliclazide—Tachycardia—Ramipril—hypertension	8.44e-06	7.79e-05	CcSEcCtD
Gliclazide—Dermatitis—Verapamil—hypertension	8.43e-06	7.79e-05	CcSEcCtD
Gliclazide—Headache—Nifedipine—hypertension	8.42e-06	7.78e-05	CcSEcCtD
Gliclazide—Pruritus—Clonidine—hypertension	8.41e-06	7.76e-05	CcSEcCtD
Gliclazide—Abdominal pain—Hydrochlorothiazide—hypertension	8.4e-06	7.76e-05	CcSEcCtD
Gliclazide—Body temperature increased—Hydrochlorothiazide—hypertension	8.4e-06	7.76e-05	CcSEcCtD
Gliclazide—Skin disorder—Ramipril—hypertension	8.4e-06	7.76e-05	CcSEcCtD
Gliclazide—Infection—Timolol—hypertension	8.4e-06	7.75e-05	CcSEcCtD
Gliclazide—Headache—Verapamil—hypertension	8.39e-06	7.75e-05	CcSEcCtD
Gliclazide—Hypersensitivity—Telmisartan—hypertension	8.39e-06	7.75e-05	CcSEcCtD
Gliclazide—Cough—Lisinopril—hypertension	8.38e-06	7.74e-05	CcSEcCtD
Gliclazide—Nausea—Indapamide—hypertension	8.37e-06	7.73e-05	CcSEcCtD
Gliclazide—Nausea—Diltiazem—hypertension	8.37e-06	7.73e-05	CcSEcCtD
Gliclazide—Hyperhidrosis—Ramipril—hypertension	8.36e-06	7.72e-05	CcSEcCtD
Gliclazide—Asthenia—Trandolapril—hypertension	8.31e-06	7.68e-05	CcSEcCtD
Gliclazide—Feeling abnormal—Losartan—hypertension	8.31e-06	7.67e-05	CcSEcCtD
Gliclazide—Urticaria—Furosemide—hypertension	8.3e-06	7.67e-05	CcSEcCtD
Gliclazide—Nervous system disorder—Timolol—hypertension	8.29e-06	7.65e-05	CcSEcCtD
Gliclazide—Nausea—Carvedilol—hypertension	8.29e-06	7.65e-05	CcSEcCtD
Gliclazide—Asthenia—Enalapril—hypertension	8.28e-06	7.65e-05	CcSEcCtD
Gliclazide—Abdominal pain—Furosemide—hypertension	8.26e-06	7.63e-05	CcSEcCtD
Gliclazide—Body temperature increased—Furosemide—hypertension	8.26e-06	7.63e-05	CcSEcCtD
Gliclazide—Gastrointestinal pain—Losartan—hypertension	8.24e-06	7.61e-05	CcSEcCtD
Gliclazide—Dizziness—Valsartan—hypertension	8.24e-06	7.61e-05	CcSEcCtD
Gliclazide—Urticaria—Betaxolol—hypertension	8.22e-06	7.59e-05	CcSEcCtD
Gliclazide—Skin disorder—Timolol—hypertension	8.21e-06	7.58e-05	CcSEcCtD
Gliclazide—Dizziness—Olmesartan—hypertension	8.2e-06	7.58e-05	CcSEcCtD
Gliclazide—Pruritus—Trandolapril—hypertension	8.2e-06	7.57e-05	CcSEcCtD
Gliclazide—Nausea—Doxazosin—hypertension	8.2e-06	7.57e-05	CcSEcCtD
Gliclazide—Arthralgia—Lisinopril—hypertension	8.18e-06	7.55e-05	CcSEcCtD
Gliclazide—Chest pain—Lisinopril—hypertension	8.18e-06	7.55e-05	CcSEcCtD
Gliclazide—Myalgia—Lisinopril—hypertension	8.18e-06	7.55e-05	CcSEcCtD
Gliclazide—Body temperature increased—Betaxolol—hypertension	8.18e-06	7.55e-05	CcSEcCtD
Gliclazide—Hyperhidrosis—Timolol—hypertension	8.17e-06	7.55e-05	CcSEcCtD
Gliclazide—Asthenia—Telmisartan—hypertension	8.17e-06	7.54e-05	CcSEcCtD
Gliclazide—Pruritus—Enalapril—hypertension	8.17e-06	7.54e-05	CcSEcCtD
Gliclazide—Anxiety—Lisinopril—hypertension	8.15e-06	7.53e-05	CcSEcCtD
Gliclazide—Diarrhoea—Clonidine—hypertension	8.13e-06	7.51e-05	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	8.12e-06	7.5e-05	CcSEcCtD
Gliclazide—Nausea—Fosinopril—hypertension	8.09e-06	7.48e-05	CcSEcCtD
Gliclazide—Discomfort—Lisinopril—hypertension	8.08e-06	7.46e-05	CcSEcCtD
Gliclazide—Hypotension—Ramipril—hypertension	8.08e-06	7.46e-05	CcSEcCtD
Gliclazide—Pruritus—Telmisartan—hypertension	8.05e-06	7.44e-05	CcSEcCtD
Gliclazide—Nausea—Eplerenone—hypertension	8.05e-06	7.43e-05	CcSEcCtD
Gliclazide—Urticaria—Losartan—hypertension	8.01e-06	7.4e-05	CcSEcCtD
Gliclazide—Dry mouth—Lisinopril—hypertension	8e-06	7.39e-05	CcSEcCtD
Gliclazide—Nausea—Nifedipine—hypertension	7.99e-06	7.38e-05	CcSEcCtD
Gliclazide—Body temperature increased—Losartan—hypertension	7.97e-06	7.36e-05	CcSEcCtD
Gliclazide—Abdominal pain—Losartan—hypertension	7.97e-06	7.36e-05	CcSEcCtD
Gliclazide—Nausea—Verapamil—hypertension	7.95e-06	7.35e-05	CcSEcCtD
Gliclazide—Asthenia—Captopril—hypertension	7.94e-06	7.34e-05	CcSEcCtD
Gliclazide—Diarrhoea—Trandolapril—hypertension	7.93e-06	7.32e-05	CcSEcCtD
Gliclazide—Vomiting—Valsartan—hypertension	7.93e-06	7.32e-05	CcSEcCtD
Gliclazide—Confusional state—Lisinopril—hypertension	7.9e-06	7.3e-05	CcSEcCtD
Gliclazide—Diarrhoea—Enalapril—hypertension	7.9e-06	7.29e-05	CcSEcCtD
Gliclazide—Hypotension—Timolol—hypertension	7.9e-06	7.29e-05	CcSEcCtD
Gliclazide—Hypersensitivity—Irbesartan—hypertension	7.89e-06	7.29e-05	CcSEcCtD
Gliclazide—Vomiting—Olmesartan—hypertension	7.89e-06	7.29e-05	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Ramipril—hypertension	7.88e-06	7.27e-05	CcSEcCtD
Gliclazide—Rash—Valsartan—hypertension	7.86e-06	7.26e-05	CcSEcCtD
Gliclazide—Dizziness—Clonidine—hypertension	7.86e-06	7.26e-05	CcSEcCtD
Gliclazide—Dermatitis—Valsartan—hypertension	7.85e-06	7.25e-05	CcSEcCtD
Gliclazide—Pruritus—Captopril—hypertension	7.83e-06	7.23e-05	CcSEcCtD
Gliclazide—Hypersensitivity—Hydrochlorothiazide—hypertension	7.83e-06	7.23e-05	CcSEcCtD
Gliclazide—Rash—Olmesartan—hypertension	7.82e-06	7.22e-05	CcSEcCtD
Gliclazide—Insomnia—Ramipril—hypertension	7.82e-06	7.22e-05	CcSEcCtD
Gliclazide—Dermatitis—Olmesartan—hypertension	7.81e-06	7.22e-05	CcSEcCtD
Gliclazide—Headache—Valsartan—hypertension	7.81e-06	7.21e-05	CcSEcCtD
Gliclazide—Diarrhoea—Telmisartan—hypertension	7.79e-06	7.19e-05	CcSEcCtD
Gliclazide—Infection—Lisinopril—hypertension	7.79e-06	7.19e-05	CcSEcCtD
Gliclazide—Headache—Olmesartan—hypertension	7.77e-06	7.18e-05	CcSEcCtD
Gliclazide—Paraesthesia—Ramipril—hypertension	7.76e-06	7.17e-05	CcSEcCtD
Gliclazide—Asthenia—Perindopril—hypertension	7.71e-06	7.12e-05	CcSEcCtD
Gliclazide—Dyspnoea—Ramipril—hypertension	7.71e-06	7.12e-05	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Timolol—hypertension	7.7e-06	7.11e-05	CcSEcCtD
Gliclazide—Hypersensitivity—Furosemide—hypertension	7.7e-06	7.11e-05	CcSEcCtD
Gliclazide—Asthenia—Irbesartan—hypertension	7.69e-06	7.1e-05	CcSEcCtD
Gliclazide—Somnolence—Ramipril—hypertension	7.68e-06	7.1e-05	CcSEcCtD
Gliclazide—Thrombocytopenia—Lisinopril—hypertension	7.68e-06	7.09e-05	CcSEcCtD
Gliclazide—Dizziness—Trandolapril—hypertension	7.66e-06	7.08e-05	CcSEcCtD
Gliclazide—Tachycardia—Lisinopril—hypertension	7.65e-06	7.07e-05	CcSEcCtD
Gliclazide—Insomnia—Timolol—hypertension	7.64e-06	7.06e-05	CcSEcCtD
Gliclazide—Dizziness—Enalapril—hypertension	7.63e-06	7.05e-05	CcSEcCtD
Gliclazide—Asthenia—Hydrochlorothiazide—hypertension	7.62e-06	7.04e-05	CcSEcCtD
Gliclazide—Hypersensitivity—Betaxolol—hypertension	7.62e-06	7.04e-05	CcSEcCtD
Gliclazide—Skin disorder—Lisinopril—hypertension	7.61e-06	7.03e-05	CcSEcCtD
Gliclazide—Dyspepsia—Ramipril—hypertension	7.61e-06	7.03e-05	CcSEcCtD
Gliclazide—Pruritus—Perindopril—hypertension	7.6e-06	7.02e-05	CcSEcCtD
Gliclazide—Paraesthesia—Timolol—hypertension	7.59e-06	7.01e-05	CcSEcCtD
Gliclazide—Pruritus—Irbesartan—hypertension	7.58e-06	7e-05	CcSEcCtD
Gliclazide—Hyperhidrosis—Lisinopril—hypertension	7.58e-06	7e-05	CcSEcCtD
Gliclazide—Diarrhoea—Captopril—hypertension	7.57e-06	7e-05	CcSEcCtD
Gliclazide—Vomiting—Clonidine—hypertension	7.55e-06	6.98e-05	CcSEcCtD
Gliclazide—Dyspnoea—Timolol—hypertension	7.53e-06	6.96e-05	CcSEcCtD
Gliclazide—Dizziness—Telmisartan—hypertension	7.53e-06	6.95e-05	CcSEcCtD
Gliclazide—Pruritus—Hydrochlorothiazide—hypertension	7.52e-06	6.94e-05	CcSEcCtD
Gliclazide—Somnolence—Timolol—hypertension	7.51e-06	6.94e-05	CcSEcCtD
Gliclazide—Asthenia—Furosemide—hypertension	7.5e-06	6.92e-05	CcSEcCtD
Gliclazide—Rash—Clonidine—hypertension	7.49e-06	6.92e-05	CcSEcCtD
Gliclazide—Dermatitis—Clonidine—hypertension	7.48e-06	6.91e-05	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Ramipril—hypertension	7.46e-06	6.89e-05	CcSEcCtD
Gliclazide—Fatigue—Ramipril—hypertension	7.45e-06	6.88e-05	CcSEcCtD
Gliclazide—Headache—Clonidine—hypertension	7.44e-06	6.88e-05	CcSEcCtD
Gliclazide—Dyspepsia—Timolol—hypertension	7.44e-06	6.87e-05	CcSEcCtD
Gliclazide—Hypersensitivity—Losartan—hypertension	7.43e-06	6.86e-05	CcSEcCtD
Gliclazide—Asthenia—Betaxolol—hypertension	7.42e-06	6.86e-05	CcSEcCtD
Gliclazide—Nausea—Valsartan—hypertension	7.4e-06	6.84e-05	CcSEcCtD
Gliclazide—Pruritus—Furosemide—hypertension	7.39e-06	6.83e-05	CcSEcCtD
Gliclazide—Constipation—Ramipril—hypertension	7.39e-06	6.83e-05	CcSEcCtD
Gliclazide—Nausea—Olmesartan—hypertension	7.37e-06	6.81e-05	CcSEcCtD
Gliclazide—Vomiting—Trandolapril—hypertension	7.37e-06	6.81e-05	CcSEcCtD
Gliclazide—Diarrhoea—Perindopril—hypertension	7.35e-06	6.79e-05	CcSEcCtD
Gliclazide—Vomiting—Enalapril—hypertension	7.34e-06	6.78e-05	CcSEcCtD
Gliclazide—Diarrhoea—Irbesartan—hypertension	7.33e-06	6.77e-05	CcSEcCtD
Gliclazide—Hypotension—Lisinopril—hypertension	7.33e-06	6.77e-05	CcSEcCtD
Gliclazide—Dizziness—Captopril—hypertension	7.32e-06	6.76e-05	CcSEcCtD
Gliclazide—Pruritus—Betaxolol—hypertension	7.32e-06	6.76e-05	CcSEcCtD
Gliclazide—Rash—Trandolapril—hypertension	7.31e-06	6.75e-05	CcSEcCtD
Gliclazide—Dermatitis—Trandolapril—hypertension	7.3e-06	6.74e-05	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Timolol—hypertension	7.3e-06	6.74e-05	CcSEcCtD
Gliclazide—Fatigue—Timolol—hypertension	7.29e-06	6.73e-05	CcSEcCtD
Gliclazide—Rash—Enalapril—hypertension	7.28e-06	6.72e-05	CcSEcCtD
Gliclazide—Dermatitis—Enalapril—hypertension	7.27e-06	6.72e-05	CcSEcCtD
Gliclazide—Diarrhoea—Hydrochlorothiazide—hypertension	7.27e-06	6.71e-05	CcSEcCtD
Gliclazide—Headache—Trandolapril—hypertension	7.26e-06	6.71e-05	CcSEcCtD
Gliclazide—Vomiting—Telmisartan—hypertension	7.24e-06	6.69e-05	CcSEcCtD
Gliclazide—Asthenia—Losartan—hypertension	7.23e-06	6.68e-05	CcSEcCtD
Gliclazide—Headache—Enalapril—hypertension	7.23e-06	6.68e-05	CcSEcCtD
Gliclazide—Pain—Timolol—hypertension	7.23e-06	6.68e-05	CcSEcCtD
Gliclazide—Rash—Telmisartan—hypertension	7.18e-06	6.63e-05	CcSEcCtD
Gliclazide—Dermatitis—Telmisartan—hypertension	7.17e-06	6.62e-05	CcSEcCtD
Gliclazide—Diarrhoea—Furosemide—hypertension	7.15e-06	6.6e-05	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Lisinopril—hypertension	7.14e-06	6.6e-05	CcSEcCtD
Gliclazide—Pruritus—Losartan—hypertension	7.13e-06	6.59e-05	CcSEcCtD
Gliclazide—Headache—Telmisartan—hypertension	7.13e-06	6.59e-05	CcSEcCtD
Gliclazide—Feeling abnormal—Ramipril—hypertension	7.12e-06	6.58e-05	CcSEcCtD
Gliclazide—Dizziness—Perindopril—hypertension	7.11e-06	6.57e-05	CcSEcCtD
Gliclazide—Insomnia—Lisinopril—hypertension	7.09e-06	6.55e-05	CcSEcCtD
Gliclazide—Dizziness—Irbesartan—hypertension	7.08e-06	6.54e-05	CcSEcCtD
Gliclazide—Diarrhoea—Betaxolol—hypertension	7.08e-06	6.54e-05	CcSEcCtD
Gliclazide—Gastrointestinal pain—Ramipril—hypertension	7.07e-06	6.53e-05	CcSEcCtD
Gliclazide—Nausea—Clonidine—hypertension	7.06e-06	6.52e-05	CcSEcCtD
Gliclazide—Paraesthesia—Lisinopril—hypertension	7.04e-06	6.5e-05	CcSEcCtD
Gliclazide—Vomiting—Captopril—hypertension	7.04e-06	6.5e-05	CcSEcCtD
Gliclazide—Dizziness—Hydrochlorothiazide—hypertension	7.03e-06	6.49e-05	CcSEcCtD
Gliclazide—Dyspnoea—Lisinopril—hypertension	6.99e-06	6.46e-05	CcSEcCtD
Gliclazide—Rash—Captopril—hypertension	6.98e-06	6.45e-05	CcSEcCtD
Gliclazide—Dermatitis—Captopril—hypertension	6.97e-06	6.44e-05	CcSEcCtD
Gliclazide—Somnolence—Lisinopril—hypertension	6.97e-06	6.44e-05	CcSEcCtD
Gliclazide—Feeling abnormal—Timolol—hypertension	6.96e-06	6.43e-05	CcSEcCtD
Gliclazide—Headache—Captopril—hypertension	6.93e-06	6.41e-05	CcSEcCtD
Gliclazide—Gastrointestinal pain—Timolol—hypertension	6.91e-06	6.38e-05	CcSEcCtD
Gliclazide—Dizziness—Furosemide—hypertension	6.91e-06	6.38e-05	CcSEcCtD
Gliclazide—Dyspepsia—Lisinopril—hypertension	6.9e-06	6.37e-05	CcSEcCtD
Gliclazide—Diarrhoea—Losartan—hypertension	6.9e-06	6.37e-05	CcSEcCtD
Gliclazide—Nausea—Trandolapril—hypertension	6.88e-06	6.36e-05	CcSEcCtD
Gliclazide—Urticaria—Ramipril—hypertension	6.87e-06	6.34e-05	CcSEcCtD
Gliclazide—Nausea—Enalapril—hypertension	6.86e-06	6.33e-05	CcSEcCtD
Gliclazide—Dizziness—Betaxolol—hypertension	6.84e-06	6.32e-05	CcSEcCtD
Gliclazide—Vomiting—Perindopril—hypertension	6.83e-06	6.31e-05	CcSEcCtD
Gliclazide—Body temperature increased—Ramipril—hypertension	6.83e-06	6.31e-05	CcSEcCtD
Gliclazide—Abdominal pain—Ramipril—hypertension	6.83e-06	6.31e-05	CcSEcCtD
Gliclazide—Vomiting—Irbesartan—hypertension	6.81e-06	6.29e-05	CcSEcCtD
Gliclazide—Rash—Perindopril—hypertension	6.78e-06	6.26e-05	CcSEcCtD
Gliclazide—Dermatitis—Perindopril—hypertension	6.77e-06	6.25e-05	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Lisinopril—hypertension	6.77e-06	6.25e-05	CcSEcCtD
Gliclazide—Nausea—Telmisartan—hypertension	6.76e-06	6.25e-05	CcSEcCtD
Gliclazide—Fatigue—Lisinopril—hypertension	6.76e-06	6.24e-05	CcSEcCtD
Gliclazide—Vomiting—Hydrochlorothiazide—hypertension	6.75e-06	6.24e-05	CcSEcCtD
Gliclazide—Rash—Irbesartan—hypertension	6.75e-06	6.24e-05	CcSEcCtD
Gliclazide—Dermatitis—Irbesartan—hypertension	6.75e-06	6.23e-05	CcSEcCtD
Gliclazide—Headache—Perindopril—hypertension	6.73e-06	6.22e-05	CcSEcCtD
Gliclazide—Urticaria—Timolol—hypertension	6.71e-06	6.2e-05	CcSEcCtD
Gliclazide—Headache—Irbesartan—hypertension	6.71e-06	6.2e-05	CcSEcCtD
Gliclazide—Constipation—Lisinopril—hypertension	6.7e-06	6.19e-05	CcSEcCtD
Gliclazide—Pain—Lisinopril—hypertension	6.7e-06	6.19e-05	CcSEcCtD
Gliclazide—Rash—Hydrochlorothiazide—hypertension	6.7e-06	6.19e-05	CcSEcCtD
Gliclazide—Dermatitis—Hydrochlorothiazide—hypertension	6.69e-06	6.18e-05	CcSEcCtD
Gliclazide—Body temperature increased—Timolol—hypertension	6.68e-06	6.17e-05	CcSEcCtD
Gliclazide—Abdominal pain—Timolol—hypertension	6.68e-06	6.17e-05	CcSEcCtD
Gliclazide—Dizziness—Losartan—hypertension	6.67e-06	6.16e-05	CcSEcCtD
Gliclazide—Headache—Hydrochlorothiazide—hypertension	6.66e-06	6.15e-05	CcSEcCtD
Gliclazide—Vomiting—Furosemide—hypertension	6.64e-06	6.14e-05	CcSEcCtD
Gliclazide—Rash—Furosemide—hypertension	6.59e-06	6.09e-05	CcSEcCtD
Gliclazide—Dermatitis—Furosemide—hypertension	6.58e-06	6.08e-05	CcSEcCtD
Gliclazide—Vomiting—Betaxolol—hypertension	6.58e-06	6.08e-05	CcSEcCtD
Gliclazide—Nausea—Captopril—hypertension	6.58e-06	6.07e-05	CcSEcCtD
Gliclazide—Headache—Furosemide—hypertension	6.55e-06	6.05e-05	CcSEcCtD
Gliclazide—Rash—Betaxolol—hypertension	6.52e-06	6.02e-05	CcSEcCtD
Gliclazide—Dermatitis—Betaxolol—hypertension	6.52e-06	6.02e-05	CcSEcCtD
Gliclazide—Headache—Betaxolol—hypertension	6.48e-06	5.99e-05	CcSEcCtD
Gliclazide—Feeling abnormal—Lisinopril—hypertension	6.46e-06	5.97e-05	CcSEcCtD
Gliclazide—Gastrointestinal pain—Lisinopril—hypertension	6.41e-06	5.92e-05	CcSEcCtD
Gliclazide—Vomiting—Losartan—hypertension	6.41e-06	5.92e-05	CcSEcCtD
Gliclazide—Nausea—Perindopril—hypertension	6.38e-06	5.9e-05	CcSEcCtD
Gliclazide—Hypersensitivity—Ramipril—hypertension	6.37e-06	5.88e-05	CcSEcCtD
Gliclazide—Nausea—Irbesartan—hypertension	6.36e-06	5.88e-05	CcSEcCtD
Gliclazide—Rash—Losartan—hypertension	6.36e-06	5.87e-05	CcSEcCtD
Gliclazide—Dermatitis—Losartan—hypertension	6.35e-06	5.87e-05	CcSEcCtD
Gliclazide—Headache—Losartan—hypertension	6.32e-06	5.83e-05	CcSEcCtD
Gliclazide—Nausea—Hydrochlorothiazide—hypertension	6.31e-06	5.83e-05	CcSEcCtD
Gliclazide—Urticaria—Lisinopril—hypertension	6.23e-06	5.75e-05	CcSEcCtD
Gliclazide—Hypersensitivity—Timolol—hypertension	6.23e-06	5.75e-05	CcSEcCtD
Gliclazide—Nausea—Furosemide—hypertension	6.21e-06	5.73e-05	CcSEcCtD
Gliclazide—Asthenia—Ramipril—hypertension	6.2e-06	5.73e-05	CcSEcCtD
Gliclazide—Abdominal pain—Lisinopril—hypertension	6.2e-06	5.72e-05	CcSEcCtD
Gliclazide—Body temperature increased—Lisinopril—hypertension	6.2e-06	5.72e-05	CcSEcCtD
Gliclazide—Nausea—Betaxolol—hypertension	6.14e-06	5.68e-05	CcSEcCtD
Gliclazide—Pruritus—Ramipril—hypertension	6.12e-06	5.65e-05	CcSEcCtD
Gliclazide—Asthenia—Timolol—hypertension	6.06e-06	5.6e-05	CcSEcCtD
Gliclazide—Nausea—Losartan—hypertension	5.99e-06	5.53e-05	CcSEcCtD
Gliclazide—Pruritus—Timolol—hypertension	5.98e-06	5.52e-05	CcSEcCtD
Gliclazide—Diarrhoea—Ramipril—hypertension	5.91e-06	5.46e-05	CcSEcCtD
Gliclazide—Diarrhoea—Timolol—hypertension	5.78e-06	5.34e-05	CcSEcCtD
Gliclazide—Hypersensitivity—Lisinopril—hypertension	5.78e-06	5.34e-05	CcSEcCtD
Gliclazide—Dizziness—Ramipril—hypertension	5.72e-06	5.28e-05	CcSEcCtD
Gliclazide—Asthenia—Lisinopril—hypertension	5.62e-06	5.2e-05	CcSEcCtD
Gliclazide—Dizziness—Timolol—hypertension	5.59e-06	5.16e-05	CcSEcCtD
Gliclazide—Pruritus—Lisinopril—hypertension	5.55e-06	5.12e-05	CcSEcCtD
Gliclazide—Vomiting—Ramipril—hypertension	5.5e-06	5.08e-05	CcSEcCtD
Gliclazide—Rash—Ramipril—hypertension	5.45e-06	5.03e-05	CcSEcCtD
Gliclazide—Dermatitis—Ramipril—hypertension	5.45e-06	5.03e-05	CcSEcCtD
Gliclazide—Headache—Ramipril—hypertension	5.42e-06	5e-05	CcSEcCtD
Gliclazide—Vomiting—Timolol—hypertension	5.37e-06	4.96e-05	CcSEcCtD
Gliclazide—Diarrhoea—Lisinopril—hypertension	5.36e-06	4.95e-05	CcSEcCtD
Gliclazide—Rash—Timolol—hypertension	5.33e-06	4.92e-05	CcSEcCtD
Gliclazide—Dermatitis—Timolol—hypertension	5.32e-06	4.92e-05	CcSEcCtD
Gliclazide—Headache—Timolol—hypertension	5.29e-06	4.89e-05	CcSEcCtD
Gliclazide—Dizziness—Lisinopril—hypertension	5.18e-06	4.79e-05	CcSEcCtD
Gliclazide—Nausea—Ramipril—hypertension	5.13e-06	4.74e-05	CcSEcCtD
Gliclazide—Nausea—Timolol—hypertension	5.02e-06	4.64e-05	CcSEcCtD
Gliclazide—Vomiting—Lisinopril—hypertension	4.98e-06	4.6e-05	CcSEcCtD
Gliclazide—Rash—Lisinopril—hypertension	4.94e-06	4.57e-05	CcSEcCtD
Gliclazide—Dermatitis—Lisinopril—hypertension	4.94e-06	4.56e-05	CcSEcCtD
Gliclazide—Headache—Lisinopril—hypertension	4.91e-06	4.54e-05	CcSEcCtD
Gliclazide—Nausea—Lisinopril—hypertension	4.66e-06	4.3e-05	CcSEcCtD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—hypertension	1.93e-06	3.16e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2C18—hypertension	1.93e-06	3.15e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LRP2—hypertension	1.93e-06	3.15e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—hypertension	1.93e-06	3.15e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALOX5AP—hypertension	1.92e-06	3.14e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALOX15—hypertension	1.92e-06	3.14e-05	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—APOA1—hypertension	1.92e-06	3.14e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—hypertension	1.9e-06	3.1e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HADHA—hypertension	1.88e-06	3.07e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LHB—hypertension	1.88e-06	3.07e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—hypertension	1.88e-06	3.07e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—hypertension	1.87e-06	3.06e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HSPG2—hypertension	1.86e-06	3.03e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF1—hypertension	1.86e-06	3.03e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT2—hypertension	1.85e-06	3.03e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—POMC—hypertension	1.85e-06	3.03e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—INS—hypertension	1.84e-06	3.01e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—hypertension	1.83e-06	3e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LPA—hypertension	1.83e-06	3e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HSD3B2—hypertension	1.83e-06	3e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—KCNJ11—hypertension	1.83e-06	3e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ALDH2—hypertension	1.83e-06	2.99e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—hypertension	1.82e-06	2.97e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—hypertension	1.81e-06	2.97e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL2—hypertension	1.81e-06	2.96e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALOX5—hypertension	1.79e-06	2.93e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GLP1R—hypertension	1.79e-06	2.93e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1—hypertension	1.78e-06	2.91e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT2—hypertension	1.78e-06	2.91e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARG—hypertension	1.78e-06	2.91e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HBA1—hypertension	1.78e-06	2.91e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP11A1—hypertension	1.77e-06	2.89e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—hypertension	1.76e-06	2.88e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SERPINE1—hypertension	1.76e-06	2.88e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LRP2—hypertension	1.76e-06	2.87e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2C18—hypertension	1.76e-06	2.87e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—POMC—hypertension	1.76e-06	2.87e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTT1—hypertension	1.74e-06	2.84e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC9A1—hypertension	1.74e-06	2.84e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCLC—hypertension	1.72e-06	2.81e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CETP—hypertension	1.72e-06	2.81e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—hypertension	1.71e-06	2.79e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—RHOA—hypertension	1.7e-06	2.78e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SERPINE1—hypertension	1.69e-06	2.77e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HSPG2—hypertension	1.69e-06	2.77e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTEN—hypertension	1.69e-06	2.76e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PIK3R1—hypertension	1.68e-06	2.75e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS3—hypertension	1.68e-06	2.75e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—hypertension	1.67e-06	2.74e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—hypertension	1.66e-06	2.71e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—hypertension	1.65e-06	2.7e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP17A1—hypertension	1.64e-06	2.69e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALDH2—hypertension	1.64e-06	2.68e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FGF2—hypertension	1.64e-06	2.68e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTEN—hypertension	1.64e-06	2.68e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALOX5—hypertension	1.63e-06	2.67e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GLP1R—hypertension	1.63e-06	2.67e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RHOA—hypertension	1.63e-06	2.67e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ENO1—hypertension	1.63e-06	2.66e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS1—hypertension	1.63e-06	2.66e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PIK3R1—hypertension	1.62e-06	2.64e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOS3—hypertension	1.62e-06	2.64e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—EP300—hypertension	1.61e-06	2.63e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—hypertension	1.6e-06	2.61e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HBA1—hypertension	1.6e-06	2.61e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP11A1—hypertension	1.59e-06	2.6e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypertension	1.58e-06	2.58e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CTGF—hypertension	1.57e-06	2.56e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—EP300—hypertension	1.56e-06	2.55e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC9A1—hypertension	1.56e-06	2.55e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTT1—hypertension	1.56e-06	2.55e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HMGCR—hypertension	1.55e-06	2.54e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GOT2—hypertension	1.55e-06	2.54e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CETP—hypertension	1.54e-06	2.52e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCLC—hypertension	1.54e-06	2.52e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	1.53e-06	2.5e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RELA—hypertension	1.52e-06	2.49e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADRA2A—hypertension	1.52e-06	2.48e-05	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—AKT1—hypertension	1.5e-06	2.45e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALDH2—hypertension	1.49e-06	2.44e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MTOR—hypertension	1.49e-06	2.44e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP17A1—hypertension	1.48e-06	2.41e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS1—hypertension	1.46e-06	2.39e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ENO1—hypertension	1.46e-06	2.39e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—hypertension	1.46e-06	2.38e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HBA1—hypertension	1.46e-06	2.38e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP11A1—hypertension	1.45e-06	2.37e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypertension	1.44e-06	2.35e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hypertension	1.44e-06	2.35e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL8—hypertension	1.43e-06	2.34e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TH—hypertension	1.42e-06	2.33e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTT1—hypertension	1.42e-06	2.32e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC9A1—hypertension	1.42e-06	2.32e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CALM2—hypertension	1.42e-06	2.32e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CTGF—hypertension	1.41e-06	2.3e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CETP—hypertension	1.41e-06	2.3e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCLC—hypertension	1.41e-06	2.3e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—hypertension	1.4e-06	2.29e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HMGCR—hypertension	1.39e-06	2.28e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GOT2—hypertension	1.39e-06	2.28e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC2A4—hypertension	1.38e-06	2.26e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCG—hypertension	1.38e-06	2.26e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	1.37e-06	2.25e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADRA2A—hypertension	1.36e-06	2.23e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP17A1—hypertension	1.35e-06	2.2e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GOT1—hypertension	1.34e-06	2.19e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ENO1—hypertension	1.33e-06	2.18e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS1—hypertension	1.33e-06	2.18e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hypertension	1.31e-06	2.14e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—STK11—hypertension	1.3e-06	2.13e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP19A1—hypertension	1.3e-06	2.13e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP9—hypertension	1.3e-06	2.12e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CDKN1A—hypertension	1.29e-06	2.11e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTEN—hypertension	1.29e-06	2.11e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CTGF—hypertension	1.28e-06	2.1e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—EP300—hypertension	1.28e-06	2.09e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TH—hypertension	1.28e-06	2.09e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CALM2—hypertension	1.27e-06	2.08e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HMGCR—hypertension	1.27e-06	2.08e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GOT2—hypertension	1.27e-06	2.08e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MAPK8—hypertension	1.26e-06	2.06e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—hypertension	1.26e-06	2.06e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	1.25e-06	2.05e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SRC—hypertension	1.24e-06	2.03e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADRA2A—hypertension	1.24e-06	2.03e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC2A4—hypertension	1.24e-06	2.03e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCG—hypertension	1.24e-06	2.03e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EP300—hypertension	1.23e-06	2.01e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.22e-06	2e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—hypertension	1.21e-06	1.98e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—COMT—hypertension	1.21e-06	1.98e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GOT1—hypertension	1.2e-06	1.97e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SRC—hypertension	1.2e-06	1.95e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GNB3—hypertension	1.19e-06	1.95e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARGC1A—hypertension	1.19e-06	1.95e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HMOX1—hypertension	1.19e-06	1.94e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAT—hypertension	1.17e-06	1.92e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—STK11—hypertension	1.17e-06	1.91e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP19A1—hypertension	1.17e-06	1.91e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—EP300—hypertension	1.16e-06	1.9e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TH—hypertension	1.16e-06	1.9e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GNAS—hypertension	1.16e-06	1.9e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CALM2—hypertension	1.16e-06	1.9e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—hypertension	1.15e-06	1.87e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOB—hypertension	1.14e-06	1.86e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC2A4—hypertension	1.13e-06	1.85e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCG—hypertension	1.13e-06	1.85e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—hypertension	1.11e-06	1.82e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTM1—hypertension	1.11e-06	1.81e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GOT1—hypertension	1.1e-06	1.79e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.1e-06	1.79e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LPL—hypertension	1.09e-06	1.78e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—COMT—hypertension	1.09e-06	1.78e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MYC—hypertension	1.07e-06	1.75e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARGC1A—hypertension	1.07e-06	1.75e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GNB3—hypertension	1.07e-06	1.75e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—hypertension	1.07e-06	1.75e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HMOX1—hypertension	1.07e-06	1.74e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP19A1—hypertension	1.07e-06	1.74e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—STK11—hypertension	1.07e-06	1.74e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADCY5—hypertension	1.06e-06	1.74e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GPX1—hypertension	1.06e-06	1.73e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAT—hypertension	1.05e-06	1.72e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PRKCA—hypertension	1.05e-06	1.72e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP1A1—hypertension	1.05e-06	1.72e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EGFR—hypertension	1.05e-06	1.71e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hypertension	1.05e-06	1.71e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GNAS—hypertension	1.04e-06	1.7e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CD36—hypertension	1.03e-06	1.69e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOB—hypertension	1.02e-06	1.67e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hypertension	1e-06	1.63e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTM1—hypertension	9.93e-07	1.62e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—COMT—hypertension	9.9e-07	1.62e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTHFR—hypertension	9.78e-07	1.6e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARGC1A—hypertension	9.76e-07	1.6e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GNB3—hypertension	9.76e-07	1.6e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LPL—hypertension	9.75e-07	1.59e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AKT1—hypertension	9.72e-07	1.59e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HMOX1—hypertension	9.72e-07	1.59e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARA—hypertension	9.59e-07	1.57e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAT—hypertension	9.59e-07	1.57e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADCY5—hypertension	9.54e-07	1.56e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hypertension	9.53e-07	1.56e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GPX1—hypertension	9.51e-07	1.56e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GNAS—hypertension	9.51e-07	1.55e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AKT1—hypertension	9.43e-07	1.54e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PRKCA—hypertension	9.42e-07	1.54e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP1A1—hypertension	9.42e-07	1.54e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOB—hypertension	9.31e-07	1.52e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AGT—hypertension	9.29e-07	1.52e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CD36—hypertension	9.26e-07	1.51e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—hypertension	9.16e-07	1.5e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CALM1—hypertension	9.14e-07	1.49e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOE—hypertension	9.1e-07	1.49e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTM1—hypertension	9.06e-07	1.48e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAV1—hypertension	9.02e-07	1.47e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOA1—hypertension	9e-07	1.47e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LPL—hypertension	8.89e-07	1.45e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—hypertension	8.8e-07	1.44e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTHFR—hypertension	8.78e-07	1.44e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADCY5—hypertension	8.7e-07	1.42e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GPX1—hypertension	8.67e-07	1.42e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARA—hypertension	8.61e-07	1.41e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PRKCA—hypertension	8.59e-07	1.4e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP1A1—hypertension	8.59e-07	1.4e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CD36—hypertension	8.45e-07	1.38e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AGT—hypertension	8.34e-07	1.36e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CALM1—hypertension	8.2e-07	1.34e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOE—hypertension	8.17e-07	1.34e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAV1—hypertension	8.1e-07	1.32e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOA1—hypertension	8.08e-07	1.32e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—hypertension	8.05e-07	1.32e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTHFR—hypertension	8e-07	1.31e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARG—hypertension	7.93e-07	1.3e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARA—hypertension	7.85e-07	1.28e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—POMC—hypertension	7.82e-07	1.28e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—INS—hypertension	7.78e-07	1.27e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT1—hypertension	7.73e-07	1.26e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AGT—hypertension	7.6e-07	1.24e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CALM1—hypertension	7.48e-07	1.22e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOE—hypertension	7.45e-07	1.22e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT1—hypertension	7.43e-07	1.21e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAV1—hypertension	7.38e-07	1.21e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOA1—hypertension	7.37e-07	1.2e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARG—hypertension	7.12e-07	1.16e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—POMC—hypertension	7.02e-07	1.15e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—INS—hypertension	6.98e-07	1.14e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NOS3—hypertension	6.82e-07	1.12e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PIK3R1—hypertension	6.82e-07	1.12e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARG—hypertension	6.49e-07	1.06e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—POMC—hypertension	6.4e-07	1.05e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALB—hypertension	6.4e-07	1.05e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—INS—hypertension	6.37e-07	1.04e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—hypertension	6.24e-07	1.02e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PIK3R1—hypertension	6.12e-07	1e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NOS3—hypertension	6.12e-07	1e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALB—hypertension	5.84e-07	9.54e-06	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—hypertension	5.6e-07	9.16e-06	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PIK3R1—hypertension	5.58e-07	9.13e-06	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NOS3—hypertension	5.58e-07	9.13e-06	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTEN—hypertension	5.44e-07	8.9e-06	CbGpPWpGaD
Gliclazide—ALB—Metabolism—EP300—hypertension	5.19e-07	8.48e-06	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—hypertension	5.11e-07	8.35e-06	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTEN—hypertension	4.88e-07	7.99e-06	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—EP300—hypertension	4.66e-07	7.62e-06	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTEN—hypertension	4.45e-07	7.28e-06	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—EP300—hypertension	4.25e-07	6.94e-06	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKT1—hypertension	3.13e-07	5.13e-06	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKT1—hypertension	2.81e-07	4.6e-06	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKT1—hypertension	2.57e-07	4.2e-06	CbGpPWpGaD
